Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for reduction of urinary protein excretion in diabetic nephropathy
IRCT138901013596N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline in type 2 diabetes mellitus (T2DM) and diabetic glomerulosclerosis, sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Change in urinary protein excretion. Started Aug 2009; status: completed.
02
Drugs
pentoxifylline
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis
Beyond the preview
Go deeper on IRCT138901013596N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138901013596N1.